Dr. Reddy’s Gets U.S. FDA Advertising Letter, But Its Response Is Far From Generic
This article was originally published in PharmAsia News
Executive Summary
Despite changes to the website, the boxed warning about the risk of epidural or spinal hematomas for patients taking generic fondaparinux still receives little emphasis on a Dr. Reddy’s promotional page.